The Oxford Club Special Opportunities

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

SPECIAL OPPORTUNITIES The TRUTH Behind Nvidia's Bizarre Biotech Investment Marc Lichtenfeld | Chief Income Strategist | The Oxford Club Dear Reader, I've just made a fascinating discovery that I couldn't wait to share with you... Nvidia recently shocked Wall Street by making a massive investment in a tiny $10 biotech stock. And we're not talking about some simple investment here... This is a major partnership. At first, this move made zero sense and had many investors perplexed. Why would Nvidia want to even operate in an entirely separate industry? However, after extensive research, the real story behind Nvidia's curious investment has become clear. You see, this small cap's technology has the power to disrupt the entire the $11 trillion healthcare, life sciences and pharma industries as we know it... I realize that's a bold statement. But on June 27 at 2 p.m. ET, I'd like to show you how. I'll share the full details on this firm's game-changing breakthrough... the fascinating backstory on Nvidia's investment... and why investors who get in before July 1 could see a shot at windfall profits. Just click here to reserve your spot before it's too late. This could be your opportunity to get in at the ground floor of a remarkable situation. Good investing, Marc You are receiving this email as a part of your membership in The Oxford Club. Oxford Club Special Opportunities is published by The Oxford Club. To unsubscribe from opportunity based emails like this one, click here. Please note that this will not impact the fulfillment of your subscription in any way.. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist The Oxford Club Special Opportunities © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.